Clinical Trial Update: The Use of DPP-4 Inhibitors in Short Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the use of DPP-4 inhibitors for Short Bowel Syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Snippet

Sponsor: Stanley Dudrick's Memorial Hospital | Conditions: Short Bowel Syndrome | Phase 4 | Status: TERMINATED